A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Johnson & Johnson stock. As of the latest transaction made, Gotham Asset Management, LLC holds 217,637 shares of JNJ stock, worth $31.4 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
217,637
Previous 218,023 0.18%
Holding current value
$31.4 Million
Previous $31.9 Million 10.68%
% of portfolio
0.37%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $56,155 - $64,608
-386 Reduced 0.18%
217,637 $35.3 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $6.6 Million - $7.21 Million
45,724 Added 26.54%
218,023 $31.9 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $1.86 Million - $1.95 Million
11,956 Added 7.46%
172,299 $27.3 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $5.15 Million - $5.62 Million
35,351 Added 28.28%
160,343 $25.1 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $1.61 Million - $1.8 Million
10,320 Added 9.0%
124,992 $19.5 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $257,764 - $277,403
-1,670 Reduced 1.44%
114,672 $19 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $3.8 Million - $4.53 Million
25,141 Added 27.57%
116,342 $18 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $828,874 - $930,233
-5,174 Reduced 5.37%
91,201 $16.1 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $3.18 Million - $3.54 Million
19,696 Added 25.69%
96,375 $15.7 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $233,447 - $258,181
-1,388 Reduced 1.78%
76,679 $13.6 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $3.87 Million - $4.4 Million
-24,489 Reduced 23.88%
78,067 $13.8 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $1.57 Million - $1.74 Million
-10,078 Reduced 8.95%
102,556 $17.5 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $7.34 Million - $8.16 Million
45,479 Added 67.72%
112,634 $18.2 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $1.68 Million - $1.81 Million
10,557 Added 18.65%
67,155 $11.1 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $9.88 Million - $11 Million
-64,562 Reduced 53.29%
56,598 $9.3 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $5.17 Million - $5.94 Million
-37,720 Reduced 23.74%
121,160 $19.1 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $5.72 Million - $6.27 Million
-40,758 Reduced 20.42%
158,880 $23.7 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $6.97 Million - $8.41 Million
54,091 Added 37.16%
199,638 $28.1 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $2.8 Million - $3.88 Million
-25,188 Reduced 14.75%
145,547 $19.1 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $23 Million - $26.4 Million
-180,415 Reduced 51.38%
170,735 $24.9 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $2.07 Million - $2.32 Million
16,288 Added 4.86%
351,150 $45.4 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $14.9 Million - $16.3 Million
113,272 Added 51.12%
334,862 $46.6 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $13.4 Million - $14.9 Million
-106,786 Reduced 32.52%
221,590 $31 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $4.52 Million - $5.43 Million
-36,757 Reduced 10.07%
328,376 $42.4 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $5.96 Million - $7.01 Million
-49,031 Reduced 11.84%
365,133 $50.5 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $2.79 Million - $3.08 Million
23,338 Added 5.97%
414,164 $50.3 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $18.9 Million - $22.3 Million
150,859 Added 62.87%
390,826 $50.1 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $20.9 Million - $22.8 Million
159,084 Added 196.68%
239,967 $33.5 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $10.5 Million - $10.9 Million
80,883
80,883 $10.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.